Baird Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
71,977
+32,221
| +81% | +$785K | ﹤0.01% | 1049 |
|
|
2025
Q1 | $825K | Buy |
39,756
+29,629
| +293% | +$615K | ﹤0.01% | 1245 |
|
|
2024
Q4 | $238K | Buy |
10,127
+1,765
| +21% | +$41.6K | ﹤0.01% | 1630 |
|
|
2024
Q3 | $214K | Sell |
8,362
-1,104
| -12% | -$28.3K | ﹤0.01% | 1648 |
|
|
2024
Q2 | $222K | Sell |
9,466
-1,460
| -13% | -$34.3K | ﹤0.01% | 1646 |
|
|
2024
Q1 | $314K | Buy |
10,926
+935
| +9% | +$26.9K | ﹤0.01% | 1539 |
|
|
2023
Q4 | $328K | Sell |
9,991
-1,477
| -13% | -$48.5K | ﹤0.01% | 1482 |
|
|
2023
Q3 | $319K | Buy |
11,468
+272
| +2% | +$7.58K | ﹤0.01% | 1482 |
|
|
2023
Q2 | $382K | Sell |
11,196
-123
| -1% | -$4.19K | ﹤0.01% | 1435 |
|
|
2023
Q1 | $340K | Sell |
11,319
-24
| -0.2% | -$722 | ﹤0.01% | 1453 |
|
|
2022
Q4 | $320K | Sell |
11,343
-631
| -5% | -$17.8K | ﹤0.01% | 1431 |
|
|
2022
Q3 | $394K | Sell |
11,974
-5,216
| -30% | -$172K | ﹤0.01% | 1361 |
|
|
2022
Q2 | $541K | Sell |
17,190
-24,812
| -59% | -$781K | ﹤0.01% | 1316 |
|
|
2022
Q1 | $1.93M | Buy |
42,002
+6,677
| +19% | +$307K | ﹤0.01% | 924 |
|
|
2021
Q4 | $2.16M | Sell |
35,325
-5,013
| -12% | -$307K | 0.01% | 906 |
|
|
2021
Q3 | $3.01M | Buy |
40,338
+11,907
| +42% | +$890K | 0.01% | 778 |
|
|
2021
Q2 | $2.63M | Sell |
28,431
-3,071
| -10% | -$284K | 0.01% | 802 |
|
|
2021
Q1 | $2.8M | Buy |
31,502
+21,853
| +226% | +$1.94M | 0.01% | 763 |
|
|
2020
Q4 | $900K | Buy |
+9,649
| New | +$900K | ﹤0.01% | 1045 |
|